Silvia Bolland, Ph.D.Twinbrook II, Room 21712441 Parklawn DriveRockville, MD 20852Phone: email@example.com
Chief, Autoimmunity and Functional Genomics Section, LIG
Our group is interested in immune inhibitory pathways and their role in preventing autoimmunity.
Dr. Bolland received her Ph.D. in molecular biology from the University of Cantabria, Spain, and received postdoctoral training at Harvard and The Rockefeller University. She joined the NIAID Laboratory of Immunogenetics in September 2001. She is the recipient of an S.L.E. Foundation Career Development Award and a Novel Research Grant Award from the Lupus Research Institute.
Left to right: Prapaporn (Bee) Pisitkun, Tanya Tarasenko, Silvia Bolland, Bethany Scott, Hang Leung, Jonathan Deane, and Hemanta Kole
Leung WH, Tarasenko T, Biesova Z, Kole H, Walsh ER, Bolland S. Aberrant antibody affinity selection in SHIP-deficient B cells. Eur J Immunol. 2013 Feb;43(2):371-81.
Walsh ER, Pisitkun P, Voynova E, Deane JA, Scott BL, Caspi RR, Bolland S. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16276-81.
Crampton SP, Deane JA, Feigenbaum L, Bolland S. Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol. 2012 Feb 1;188(3):1451-9.
Waisberg M, Tarasenko T, Vickers BK, Scott BL, Willcocks LC, Molina-Cruz A, Pierce MA, Huang CY, Torres-Velez FJ, Smith KG, Barillas-Mury C, Miller LH, Pierce SK, Bolland S. Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1122-7.
Crampton SP, Voynova E, Bolland S. Innate pathways to B-cell activation and tolerance. Ann N Y Acad Sci. 2010 Jan;1183:58-68.
Bolland S. An innate path to human B cell tolerance. Immunity. 2008 Nov 14;29(5):667-9.
Visit PubMed for a complete publication listing.
Last Updated August 21, 2013